These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35235177)

  • 1. Transmissibility and pathogenicity of SARS-CoV-2 variants in animal models.
    Kim YI; Casel MAB; Choi YK
    J Microbiol; 2022 Mar; 60(3):255-267. PubMed ID: 35235177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferrets: A powerful model of SARS-CoV-2.
    Zhao Y; Wang CL; Gao ZY; Qiao HX; Wang WJ; Liu XY; Chuai X
    Zool Res; 2023 Mar; 44(2):323-330. PubMed ID: 36799224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19.
    Tiwari S; Goel G; Kumar A
    Int Rev Immunol; 2024; 43(1):13-32. PubMed ID: 35757923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 immunity in animal models.
    Chen Z; Yuan Y; Hu Q; Zhu A; Chen F; Li S; Guan X; Lv C; Tang T; He Y; Cheng J; Zheng J; Hu X; Zhao J; Zhao J; Sun J
    Cell Mol Immunol; 2024 Feb; 21(2):119-133. PubMed ID: 38238440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
    Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
    Elife; 2022 Feb; 11():. PubMed ID: 35191378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model.
    Pulit-Penaloza JA; Belser JA; Sun X; Pappas C; Brock N; Kieran TJ; Ritter JM; Seixas JN; Jones J; Basu Thakur P; Pusch E; Wang L; Tumpey TM; Wentworth DE; Zhou B; Maines TR
    mBio; 2022 Oct; 13(5):e0242122. PubMed ID: 36135377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19.
    Yan F; Li E; Wang T; Li Y; Liu J; Wang W; Qin T; Su R; Pei H; Wang S; Feng N; Zhao Y; Yang S; Xia X; Gao Y
    Front Immunol; 2022; 13():821664. PubMed ID: 35197985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies.
    Gong W; Parkkila S; Wu X; Aspatwar A
    Int Rev Immunol; 2023; 42(6):393-414. PubMed ID: 35635216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B.1.351 SARS-CoV-2 Variant Exhibits Higher Virulence but Less Viral Shedding than That of the Ancestral Strain in Young Nonhuman Primates.
    Bai Y; He Q; Yang J; Lu S; Mao Q; Gao F; Bian L; Zhang J; An C; Liu J; Wu X; Yu W; Wang Z; Peng X; Wang J; Liang Z; Xu M
    Microbiol Spectr; 2022 Oct; 10(5):e0226322. PubMed ID: 36069561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current State of Knowledge about Role of Pets in Zoonotic Transmission of SARS-CoV-2.
    Dróżdż M; Krzyżek P; Dudek B; Makuch S; Janczura A; Paluch E
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34208484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Aerosol and Intranasal Exposure Models in Ferrets.
    Zumbrun EE; Zak SE; Lee ED; Bowling PA; Ruiz SI; Zeng X; Koehler JW; Delp KL; Bakken RR; Hentschel SS; Bloomfield HA; Ricks KM; Clements TL; Babka AM; Dye JM; Herbert AS
    Viruses; 2023 Nov; 15(12):. PubMed ID: 38140582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models for COVID-19: advances, gaps and perspectives.
    Fan C; Wu Y; Rui X; Yang Y; Ling C; Liu S; Liu S; Wang Y
    Signal Transduct Target Ther; 2022 Jul; 7(1):220. PubMed ID: 35798699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
    Toomer G; Burns W; Garcia L; Henry G; Biancofiori A; George A; Duffy C; Chu J; Sides M; Muñoz M; Garcia K; Nikolai-Yogerst A; Peng X; Westfall L; Baker R
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants of SARS CoV-2: mutations, transmissibility, virulence, drug resistance, and antibody/vaccine sensitivity.
    Prüβ BM
    Front Biosci (Landmark Ed); 2022 Feb; 27(2):65. PubMed ID: 35227008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2.
    Lee SJ; Kim YJ; Ahn DG
    J Microbiol Biotechnol; 2022 Sep; 32(9):1073-1085. PubMed ID: 36039385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronicling the 3-year evolution of the COVID-19 pandemic: analysis of disease management, characteristics of major variants, and impacts on pathogenicity.
    Pitsillou E; Yu Y; Beh RC; Liang JJ; Hung A; Karagiannis TC
    Clin Exp Med; 2023 Nov; 23(7):3277-3298. PubMed ID: 37615803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.
    Riddell S; Goldie S; McAuley AJ; Kuiper MJ; Durr PA; Blasdell KR; Tachedjian M; Druce JD; Smith TRF; Broderick KE; Vasan SS
    Front Immunol; 2021; 12():694857. PubMed ID: 34248993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.